{
    "clinical_study": {
        "@rank": "119175", 
        "arm_group": [
            {
                "arm_group_label": "SUBLIVAC FIX Phleum prat. 0 AUN/ml", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "SUBLIVAC FIX Phleum prat. 3,333 AUN/ml", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "SUBLIVAC FIX phleum prat. 10,000 AUN/ml", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "SUBLIVAC FIX phleum prat. 20,000 AUN/ml", 
                "arm_group_type": "Experimental", 
                "description": "Evaluation of the SUBLIVAC FIX Phleum prat. 20,000 AUN/ml by an independent safety committee"
            }, 
            {
                "arm_group_label": "SUBLIVAC FIX Phleum prat. 40,000 AUN/ml", 
                "arm_group_type": "Experimental", 
                "description": "Start of SUBLIVAC FIX Phleum prat. 40,000 AUN/ml arm depends on safety in the SUBLIVAC FIX Phleum prat. 20,000 AUN/ml arm evaluated by an independent safety committee"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study is to determine the optimal effective dose of SUBLIVAC FIX Phleum\n      pratense based on reduction of upper airways reactivity after 5 months of treatment with\n      different dosages of SUBLIVAC FIX Phleum pratense compared to placebo. Furthermore, safety\n      and tolerability will be assessed by the number of related Adverse Events of different\n      dosages of SUBLIVAC FIX Phleum pratense compared to placebo."
        }, 
        "brief_title": "SUBLIVAC FIX Phleum Pratense DT/DRF", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Allergic Rhinitis", 
            "Allergic Rhinoconjunctivitis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Rhinitis", 
                "Conjunctivitis, Allergic", 
                "Conjunctivitis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Signed informed consent\n\n          -  Age \u2265 18 \u2264 60 years\n\n          -  Allergic rhinitis/rhinoconjunctivitis related to grass pollen with or without\n             concomitant mild to moderate persistent asthma\n\n          -  FEV1 > 70% for patients with a history of asthma, FEV > 70% or PEF > 80% for patients\n             without a history of asthma\n\n          -  A positive SPT (mean wheal diameter \u2265 3mm compared to negative control and negative\n             control should be negative) for grass pollen assessed within 1 year before\n             randomization.\n\n          -  Positive serum specific anti-grass IgE-test (> 0.7 U/mL)\n\n          -  A positive TNPT for grass pollen at screening (Lebel score \u2265 6) at \u226410,000 AU/mL\n\n        Exclusion Criteria:\n\n          -  Patients with (expected) clinically relevant symptoms during the course of the trial\n             due to concomitant sensitization i.e. positive SPT (mean wheal diameter \u2265 3mm) to\n             allergens other than grass pollen\n\n          -  Patients sensitized to pets should not be included if they are regularly exposed to\n             pets and are symptomatic upon exposure to pets\n\n          -  Completed immunotherapy (SCIT or SLIT) with grass pollen allergens within the past 5\n             years\n\n          -  Completed unsuccessful specific immunotherapy in the past\n\n          -  Vaccination within one week before start of therapy or during the initiation phase\n\n          -  Anti-IgE therapy within the 6 months prior to inclusion and during the study\n\n          -  Severe immune disorders (including auto-immune diseases) and/or diseases requiring\n             immunosuppressive drugs\n\n          -  Active malignancies or any malignant disease during the previous 5 years\n\n          -  Severe uncontrolled diseases that could increase the risk for patients participating\n             in the study, including but not limited to: cardiovascular insufficiency, any severe\n             or unstable lung diseases, endocrine diseases, clinically significant renal or\n             hepatic diseases, or haematological disorders\n\n          -  Active inflammation or infection of the target organs (nose, eyes or lower airways)\n             at the start of the study\n\n          -  Moderate to severe nasal obstructive diseases that preclude a TNPT (septal deviation,\n             nasal polyps, recent nasal surgery, etc.)\n\n          -  Diseases with a contraindication for the use of Adrenaline (e.g. hyperthyroidism,\n             glaucoma)\n\n          -  Use of systemic steroids within 4 weeks before start of the study and during the\n             study\n\n          -  Treatment with systemic and local \u03b2-blockers\n\n          -  Participation in a clinical study with a new investigational drug within the last 3\n             months or for a biological within the last 6 months prior to or during the study\n\n          -  Pregnancy, lactation or inadequate contraceptive measures for women of child-bearing\n             age (adequate contraceptive measures will be the use of a contraceptive device or\n             -pill)\n\n          -  Alcohol, drug or medication abuse within the past year\n\n          -  Any clinically significant abnormal laboratory parameter at screening\n\n          -  Lack of cooperation or compliance\n\n          -  Severe psychiatric, psychological, or neurological disorders\n\n          -  Patients who are employees of the institution or 1st grade relatives or partners of\n             the investigator"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "266", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 6, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01682070", 
            "org_study_id": "SP/0036"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "SUBLIVAC FIX Phleum prat. 3,333 AUN/ml", 
                    "SUBLIVAC FIX phleum prat. 10,000 AUN/ml", 
                    "SUBLIVAC FIX phleum prat. 20,000 AUN/ml", 
                    "SUBLIVAC FIX Phleum prat. 40,000 AUN/ml"
                ], 
                "description": "Comparison of different dosages to placebo", 
                "intervention_name": "SUBLIVAC FIX phleum prat.", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "SUBLIVAC FIX Phleum prat. 0 AUN/ml", 
                "intervention_name": "Placebo", 
                "intervention_type": "Biological"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Sublingual immunotherapy", 
            "Dose range finding", 
            "Dose tolerability", 
            "grass pollen", 
            "Allergic rhinitis/rhinoconjunctivitis", 
            "Safety", 
            "Immunogenicity"
        ], 
        "lastchanged_date": "May 28, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Bamberg", 
                        "country": "Germany", 
                        "zip": "96049"
                    }, 
                    "name": "CIMS Studienzentrum Bamberg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "10117"
                    }, 
                    "name": "Charit\u00e9 Universitaetsmedizin Berlin Klinik f. Dermatalogie, Venerologie u. Allergologie, Campus Charit\u00e9 Mitte"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bonn", 
                        "country": "Germany", 
                        "zip": "53105"
                    }, 
                    "name": "Klinik u. Poliklinik f. Dermatologie u. Allergologie Universit\u00e4t Bonn"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamburg", 
                        "country": "Germany", 
                        "zip": "20354"
                    }, 
                    "name": "Dermatologikum Hamburg - Dept. of Allergology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Heidelberg", 
                        "country": "Germany", 
                        "zip": "69120"
                    }, 
                    "name": "HNO Praxis Dr. Horn/Dr. Zeuner"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hessen", 
                        "country": "Germany", 
                        "zip": "60590"
                    }, 
                    "name": "Klinikum der Johann-Wolfgang-Goethe Universit\u00e4t - Zentrum f. Kinder- u. Jugendmedizin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hildesheim", 
                        "country": "Germany", 
                        "zip": "31134"
                    }, 
                    "name": "Dres.Ina R\u00f6hrig-Petering und Holger Petering"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saalfeld /Saale", 
                        "country": "Germany", 
                        "zip": "07318"
                    }, 
                    "name": "F\u00c4 HNO Allergologie"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stuttgart", 
                        "country": "Germany", 
                        "zip": "70174"
                    }, 
                    "name": "Klinikum Stuttgart - Klinik f. Dermatologie u. Allergologie"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "T\u00fcbingen", 
                        "country": "Germany", 
                        "zip": "72076"
                    }, 
                    "name": "Universit\u00e4ts- Hautklinik Eberhard Karls - Universit\u00e4t T\u00fcbingen Department of Dermatology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wolmirstedt", 
                        "country": "Germany", 
                        "zip": "393 26"
                    }, 
                    "name": "Dr. Med. Ulrich Neumann"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bia\u0142ystok", 
                        "country": "Poland", 
                        "zip": "15-430"
                    }, 
                    "name": "Prywatna Praktyka Lekarska Gabinet Pediatryczno-Alergologiczny"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bie\u0144k\u00f3wka", 
                        "country": "Poland", 
                        "zip": "PL-34 212"
                    }, 
                    "name": "SP-ZOZ O\u015brodek Zdrowia w Bie\u0144k\u00f3wce"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cieszyn", 
                        "country": "Poland", 
                        "zip": "43-400"
                    }, 
                    "name": "NZOS \"Zdrowie\""
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Katowice", 
                        "country": "Poland", 
                        "zip": "40-952"
                    }, 
                    "name": "Poradnia Alergologiczna Samodzielnego Publicznego Szpitala Nr 5 Slaskiego Uniwersytetu Medycznego w Katowicach"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lodz", 
                        "country": "Poland", 
                        "zip": "90-153"
                    }, 
                    "name": "Poradnia Alergologii i Chor\u00f3b P\u0142uc SP ZOZ Uniwersytecki Szpital Kliniczny im Norberta Barlickiego w \u0141odzi"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lublin", 
                        "country": "Poland", 
                        "zip": "20-089"
                    }, 
                    "name": "ALERGOPNEUMA Marek Michnar i Wspolnicy Sp. Jawna"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lublin", 
                        "country": "Poland", 
                        "zip": "20-522"
                    }, 
                    "name": "NZOZ Centrum Alergologii"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pozna\u0144", 
                        "country": "Poland", 
                        "zip": "60-214"
                    }, 
                    "name": "Centrum Alergologii Teresa Hofman"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tarn\u00f3w", 
                        "country": "Poland", 
                        "zip": "33-100"
                    }, 
                    "name": "ALERGOMED Specjalistyczna Przychodnia Lekarska Sp. z o.o."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wroc\u0142aw", 
                        "country": "Poland", 
                        "zip": "50-220"
                    }, 
                    "name": "EMC Intytut Medyczny S.A. Przychodnia przy \u0141owieckiej"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wroc\u0142aw", 
                        "country": "Poland", 
                        "zip": "50-434"
                    }, 
                    "name": "NZOZ Lekarze Specjali\u015bci J. Ma\u0142olepszy i Partnerzy"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "\u0141\u00f3d\u017a", 
                        "country": "Poland", 
                        "zip": "90-553"
                    }, 
                    "name": "NZOZ Centrum Alergologii"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Germany", 
                "Poland"
            ]
        }, 
        "number_of_arms": "5", 
        "official_title": "A Randomized, Double-blind, Placebo-controlled Study to Determine Safety, Tolerability and the Optimal Effective Dose of SUBLIVAC FIX Phleum Pratense in Patients With Allergic Rhinitis/Rhinoconjunctivitis Caused by Grass Pollen", 
        "overall_official": {
            "affiliation": "Allergy and Respiratory Diseases University of Genoa", 
            "last_name": "Walter G. Canonica, Prof. Dr.", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Poland: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products", 
                "Germany: Paul-Ehrlich-Institut"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Nasal Provocation Test (NPT)", 
                "safety_issue": "No", 
                "time_frame": "5 months"
            }, 
            {
                "measure": "Number of related AEs", 
                "safety_issue": "Yes", 
                "time_frame": "First ten days of study medication intake"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01682070"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Serum specific immunoglobulin levels (IgE, IgG, IgG4)", 
                "safety_issue": "No", 
                "time_frame": "5 months"
            }, 
            {
                "measure": "Number of local and systemic reactions", 
                "safety_issue": "Yes", 
                "time_frame": "Duration of study medication intake (approximately 5 months)"
            }, 
            {
                "measure": "Peak Nasal Inspiratory Flow (PNIF)", 
                "safety_issue": "No", 
                "time_frame": "5 months"
            }
        ], 
        "source": "HAL Allergy", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "HAL Allergy", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}